What is Metastatic Breast Cancer?
Metastatic breast cancer refers to the cancer cells spilling out of the breast and splashing to other organs such as bone, lungs, and liver. Early diagnosed breast cancers can metastasize in the future and 10% of breast cancer cases are metastatic. Metastatic breast cancer is a chronic disease such as hypertension, diabetes, completely untreatable, but can be controlled by modern medical methods. The aim of treatment in metastatic breast cancer is to control the disease and to ensure that the patient lives with the disease in a high quality way by using modern treatment methods such as hypertension and diabetes patients. Metastatic breast cancer has become a disease we are afraid of, which is a fatal disease, which we can control with innovative treatment methods. For example, in the treatment of hormone-sensitive breast cancer patients who make up a large part of the patients, chemotherapy applications are gradually coming out of our practice. Hormonal therapies and the targeted agents used in the treatment of these patients significantly prolonged the life expectancy and provided the protection of the patient’s quality of life. Disease control can be achieved with these treatments for many years. Considering the rate of progress in this area, it is possible to indicate that metastatic breast cancer may be completely improved in the near future.
Metastatic Breast Cancer Treatment 2019
Breast cancer is mainly divided into 3 subgroups: Hormone receptor positive, HER2 positive and triple negative. The characteristics of these subgroups are different and they are all treated differently. Depending on the type of breast cancer, chemotherapy, hormone therapy and radiotherapy, as well as classical treatment methods, targeted therapies, intelligent molecules, monoclonal antibodies, immunotherapy methods are frequently used. The largest group of patients are estrogen-sensitive hormone receptor-positive groups, and hormonal therapy is used more often than chemotherapy in the treatment of this group of patients, and there are more and more groundbreaking therapies. In this area, which has been deprived of a new treatment option for about 10 years, agents that block the cell cycle have brought a new breath. The main purpose of this patient group is to prevent the development of hormonal resistance. Thus, with new treatment options that postpone the development of resistance, patients may be offered the opportunity to stay away from the corrosive side effects of chemotherapy treatment for longer. These treatment options delay the progression of disease up to 2 years when used in conjunction with hormonal treatments.
Breast Cancer Risk Factor
Aging, genes, family history of breast cancer, obesity, alcohol and cigarette use, radiotherapy to the chest region in childhood and adolescence, geographic and social factors have been shown to increase the risk of breast cancer. In addition, long term exposure to estrogen and progestron hormones, early menopausal, late menopause, giving no birth or giving birth after 30 years of age, long-term estrogen and progestron drug use, such as IVF treatment may increase the risk of breast cancer. However, breast cancer can occur without any of the reasons mentioned above.
Get real time update about this post categories directly on your device, subscribe now.